CA2404501A1 - Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides - Google Patents
Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides Download PDFInfo
- Publication number
- CA2404501A1 CA2404501A1 CA002404501A CA2404501A CA2404501A1 CA 2404501 A1 CA2404501 A1 CA 2404501A1 CA 002404501 A CA002404501 A CA 002404501A CA 2404501 A CA2404501 A CA 2404501A CA 2404501 A1 CA2404501 A1 CA 2404501A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- polynucleotide
- protein
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54021700A | 2000-03-31 | 2000-03-31 | |
US09/540,217 | 2000-03-31 | ||
US64916700A | 2000-08-23 | 2000-08-23 | |
US09/649,167 | 2000-08-23 | ||
US78474801A | 2001-02-14 | 2001-02-14 | |
US09/784,748 | 2001-02-14 | ||
PCT/US2001/010462 WO2001075064A2 (en) | 2000-03-31 | 2001-03-30 | Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2404501A1 true CA2404501A1 (en) | 2001-10-11 |
Family
ID=27415319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002404501A Abandoned CA2404501A1 (en) | 2000-03-31 | 2001-03-30 | Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1268510A4 (ja) |
JP (1) | JP2004500120A (ja) |
AU (2) | AU2001255214B2 (ja) |
CA (1) | CA2404501A1 (ja) |
WO (1) | WO2001075064A2 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002081515A1 (fr) * | 2001-04-03 | 2002-10-17 | Kyowa Hakko Kogyo Co., Ltd. | Proteine de liaison de facteur de croissance de type insuline |
US7217796B2 (en) | 2002-05-24 | 2007-05-15 | Schering Corporation | Neutralizing human anti-IGFR antibody |
EP1670822A2 (en) | 2003-10-03 | 2006-06-21 | Genentech, Inc. | Igf binding proteins |
US7326567B2 (en) | 2003-11-12 | 2008-02-05 | Schering Corporation | Plasmid system for multigene expression |
PE20050928A1 (es) | 2003-11-21 | 2005-11-08 | Schering Corp | Combinaciones terapeuticas de anticuerpo anti-igfr1 |
JP2008521907A (ja) | 2004-12-03 | 2008-06-26 | シェーリング コーポレイション | 抗igf1r治療について患者を予め選択するためのバイオマーカー |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
WO2001094416A2 (en) * | 2000-06-07 | 2001-12-13 | Curagen Corporation | Human proteins and nucleic acids encoding same |
-
2001
- 2001-03-30 EP EP01928344A patent/EP1268510A4/en not_active Withdrawn
- 2001-03-30 AU AU2001255214A patent/AU2001255214B2/en not_active Ceased
- 2001-03-30 AU AU5521401A patent/AU5521401A/xx active Pending
- 2001-03-30 JP JP2001572939A patent/JP2004500120A/ja not_active Withdrawn
- 2001-03-30 CA CA002404501A patent/CA2404501A1/en not_active Abandoned
- 2001-03-30 WO PCT/US2001/010462 patent/WO2001075064A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001075064A2 (en) | 2001-10-11 |
AU2001255214B2 (en) | 2006-06-08 |
EP1268510A4 (en) | 2003-05-28 |
WO2001075064A3 (en) | 2002-02-28 |
AU5521401A (en) | 2001-10-15 |
JP2004500120A (ja) | 2004-01-08 |
EP1268510A2 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7981413B2 (en) | Methods and compositions concerning antibodies that bind CD84-like polypeptides | |
CA2402293A1 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A2 (en) | Novel nucleic acids and polypeptides | |
WO2001064834A2 (en) | Novel nucleic acids and polypeptides | |
AU2734401A (en) | Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides | |
EP1574520A2 (en) | Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides | |
AU2001255214B2 (en) | Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides | |
WO2001053453A2 (en) | Novel bone marrow nucleic acids and polypeptides | |
US20060073514A1 (en) | Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides | |
AU2001255214A1 (en) | Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides | |
CA2441006A1 (en) | Methods and materials relating to fibulin-like polypeptides and polynucleotides | |
US20030144491A1 (en) | Methods and materials relating to cadherin-like polypeptides and polynucleotides | |
US20050170374A1 (en) | Novel nucleic acids and polypeptides | |
WO2001075093A1 (en) | Novel nucleic acids and polypeptides | |
AU2593601A (en) | Methods and materials relating to prothrombinase-like polypeptides and polynucleotides | |
AU3655301A (en) | Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides | |
CA2399649A1 (en) | Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides | |
CA2398215A1 (en) | Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides | |
WO2001064840A2 (en) | Novel bone marrow nucleic acids and polypeptides | |
CA2399686A1 (en) | Methods and materials relating to cub domain polypeptides and polynucleotides | |
WO2001055442A2 (en) | Novel bone marrow nucleic acids and polypeptides | |
WO2001088091A2 (en) | Novel bone marrow nucleic acids and polypeptides | |
CA2395763A1 (en) | Methods and materials relating to semaphorin-like polypeptides and polynucleotides | |
CA2395770A1 (en) | Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides | |
CA2399644A1 (en) | Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |